project id: TCGA-ESCA; case submitter id: TCGA-V5-AASV; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.39; rna integrity number: 8.0; age at index: 67; days to birth: -24559; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; age at diagnosis: 24559; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 467.0; icd 10 code: C15.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Esophagus, NOS; synchronous malignancy: No; tissue or organ of origin: Esophagus, NOS; tumor grade: Not Reported; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 10.0; portion submitter id: TCGA-V5-AASV-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;